About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT02017483

Explore the Association Between the Emotion Recognition and the Attention Processing Under the Emotional Stimuli in ADHD

Lots of studies suggest that children with ADHD have deficits in facial emotion recognition, especially for the negative emotion. But there were arguments for this deficit is a secondary problem due t...

Lead sponsor: National Taiwan University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Susan Shur-Fen Gau, MD, PhD

CONTACT

886-2-23123456 gaushufe@ntu.edu.tw

Sponsors

Lead Sponsor

National Taiwan University Hospital

Collaborators

National Science and Technology Council, Taiwan

The sample will consist of 100 children and adolescent with ADHD and 100 typical controls, ages 8-16. The ADHD group inclusion criteria are patients who have clinically diagnosis of DSM-IV ADHD confirmed by the K-SADS-E, and have IQ \> 80; and whose parents consent to this study. The measurements will be included: 1. Diagnostic assessment tools: * Chinese version of Kiddie-Schedule for Affective Disorders and Schizophrenia-Epidemiology version. * Conners' Parent/Teacher Rating Scale- Revised: Short Form, CPRS-R:S/CTRS-R:S. * Swanson, Nolan, and Pelham, Version Ⅳ（SNAP-Ⅳ）Rating Scale - Parent/ Teacher Form. 2. Emotion assessment tools: * Facial emotion recognition task. * Emotional attentional bias task. * Emotional Go/ No Go task. 3. Cognitive assessment tool: * Wechsler Intelligence Scale for Children-Fourth Edition Chinese Version. This study could offer the suggestion for the further intervention of social function in ADHD.

Age

8 - 16 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Control group
•* The subjects without ADHD.
•* Ages range from 8 to 16
•* Full scale IQ ≥ 80
•* The subjects who and whose parents consent to this study.
•2. ADHD group
•* Patients who have clinically diagnosis of DSM-IV ADHD confirmed by the K-SADS-E.
•* Ages range from 8 to 16
•* Full scale IQ ≥ 80
•* Patients who and whose parents consent to this study.

Exclusion Criteria

•Mental Retardation
•Schizophrenia, Schizoaffective Disorder
•Mood Disorders
•Organic Psychosis
•Learning Disorder
•Pervasive Developmental Disorder

Related studies

Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)

NCT06133231 · Attention Deficit/Hyperactivity Disorder, Emotional Dysfunction, and more

COMPLETEDPhase 4

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

NCT05721235 · Attention Deficit/Hyperactivity Disorder

COMPLETEDPhase 1

To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, Hard Lisdexamfetamine Dimesylate in Healthy, Adult, Human Subjects Under Fasting Conditions.

NCT07098585 · Attention Deficit/Hyperactivity Disorder (ADHD)

COMPLETEDEARLY Phase 1

Oxytocin and Cognitive Control in Adult ADHD

NCT03136263 · Attention Deficit/Hyperactivity Disorder

A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting

NCT04189575 · Attention Deficit/Hyperactivity Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 20, 2013Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment200

Start dateJul 2013

Last updatedDec 20, 2013

Condition

Attention Deficit/Hyperactivity Disorder

Locations shown

National Taiwan Univeristy Hospital

Taipei

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 20, 2013Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions